10 Results for "

DYRK1-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "DYRK1-IN-1" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-132308
CAS No.: 2814486-79-6
Purity:  99.71%
Target:  

DYRK

Research Areas:  

Neurological Disease

DYRK1-IN-1 is a highly selective and ligand-efficient DYRK1A inhibitor. DYRK1-IN-1 inhibits DYRK1A phosphorylation activity with an IC50 value of 220 nM. DYRK1-IN-1 can be used for the research of central nervous system penetrant DYRK1A chemical probe .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-X0009
CAS No.: 2247481-08-7
Synonyms: GFH009; JSH-009; SLS009
Tambiciclib (GFH009, JSH-009) is an orally active, highly potent and selective CDK9 inhibitor (IC50 = 1 nM), demonstrating >200-fold selectivity over other CDKs, >100-fold selectivity over DYRK1A/B, and excellent selectivity over 468 kinases/mutants. Tambiciclib demonstrates potent in vitro and in vivo antileukemic efficacy in acute myeloid leukemia (AML) mouse models by inhibiting RNA Pol II phosphorylation, downregulating MCL1 and MYC, and inducing apoptosis. Tambiciclib can be used for AML research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-X0009A
CAS No.: 2559759-04-3
Synonyms: GFH009 dimaleate; JSH-009 dimaleate; SLS009 dimaleate
Tambiciclib (GFH009, JSH-009) dimaleate is an orally active, highly potent and selective CDK9 inhibitor (IC50 = 1 nM), demonstrating >200-fold selectivity over other CDKs, >100-fold selectivity over DYRK1A/B, and excellent selectivity over 468 kinases/mutants. Tambiciclib dimaleate demonstrates potent in vitro and in vivo antileukemic efficacy in acute myeloid leukemia (AML) mouse models by inhibiting RNA Pol II phosphorylation, downregulating MCL1 and MYC, and inducing apoptosis. Tambiciclib dimaleate can be used for AML research .
loading...
    loading...
Cat. No.: HY-15951
CAS No.: 1285702-20-6
Synonyms: CID44968231; NCGC00188654
Target:  

CDK DYRK

Research Areas:  

Cancer

ML167 is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor with IC50 of 136 nM, >10-fold selectivity for closely related kinases Clk1, Clk2, Clk3 and Dyrk1A/1B .
loading...
    loading...
Cat. No.: HY-139830
CAS No.: 2858696-72-5
Target:  

DYRK

Research Areas:  

Neurological Disease

Dyrk1A-IN-1 is a triple inhibitor of Dyrk1A kinase activity (IC50 = 119 nM) and the aggregation of tau and α-syn oligomers.
loading...
    loading...
Cat. No.: HY-144617
CAS No.: 2426628-29-5
Target:  

DYRK

Research Areas:  

Cancer

JH-XIV-68-3 is a selective macrocyclic inhibitor of DYRK1A/B. JH-XIV-68-3 displays selectivity for DYRK1A and close family member DYRK1B in biochemical and cellular assays. JH-XIV-68-3 demonstrates antitumor efficacy in head and neck squamous cell carcinoma (HNSCC) cell lines .
loading...
    loading...
Cat. No.: HY-146337
CAS No.: 3032401-50-3
Target:  

DYRK

Research Areas:  

Cancer

Dyrk1A/B-IN-1 (compound 3n) is a potent, selective and cell-permeable DYRK1A and DYRK1B inhibitor with Kis of 67.8 nM and 237.9 nM, and IC50s of 1.1 μM and 0.8 μM, respectively. Dyrk1A/B-IN-1 is not toxic to human cells. Dyrk1A/B-IN-1 can be used for researching DYRK1A and DYRK1B cellular functions and their role in pathologies .
loading...
    loading...
Cat. No.: HY-144695
CAS No.: 2789711-47-1
Target:  

DYRK

Research Areas:  

Neurological Disease

Dyrk1A/α-synuclein-IN-1 (Compound b1) is a dual Dyrk1A and α-synuclein aggregation inhibitor with IC50 values of 177 nM and 10.5 µM, respectively. Dyrk1A/α-synuclein-IN-1 has high predictive CNS penetration and neuroprotective effect .
loading...
    loading...
Cat. No.: HY-W067583
CAS No.: 6253-19-6
Target:  

Monoamine Oxidase DYRK

Research Areas:  

Others

Norharmine is a Harmine analogue and an alkaloid. Norharmine is the inhibitors of MAO-A and DYRK1A. Norharmine has weak inhibitory activity against MAO-A and certain inhibitory activity against DYRK1A .
loading...
    loading...
Cat. No.: HY-179538
Research Areas:  

Cancer

CSH-4044 can be isolated from fermented wheat germ extract. CSH-4044 is a unique benzothiazole compound. CSH-4044 can inhibit PIM3-driven BAD phosphorylation in pancreatic cancer cell lines as well as reducing DYRK1A-induced Tau phosphorylation in neuronal cells .
loading...
    loading...